- 全部删除
- 您的购物车当前为空
FXIa-IN-16 (Compound 43) 是一种口服活性和选择性FXIa抑制剂,其IC50为0.19 nM。FXIa-IN-16 在抗凝和抗血栓方面表现出强效,并在小鼠实验中显示出良好的安全性,适用于血栓形成相关研究。
FXIa-IN-16 (Compound 43) 是一种口服活性和选择性FXIa抑制剂,其IC50为0.19 nM。FXIa-IN-16 在抗凝和抗血栓方面表现出强效,并在小鼠实验中显示出良好的安全性,适用于血栓形成相关研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | FXIa-IN-16 (Compound 43) is an orally active and selective FXIa inhibitor with an IC50 of 0.19 nM. It demonstrates significant anticoagulant and antithrombotic properties and exhibits a good safety profile in mice. FXIa-IN-16 is applicable in research related to thrombosis treatment. |
分子量 | 504.904 |
分子式 | C24H18ClFN8O2 |
CAS No. | 3046390-69-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容